H. pylori Ag Screening(Stool) at Lahore PCR Lab

H. pylori Ag Screening (Stool) at Lahore PCR Lab

Helicobacter pylori (H. pylori) is a spiral-shaped, Gram-negative bacterium that colonizes the mucosal lining of the human stomach. It is one of the most common chronic bacterial infections worldwide, affecting more than half of the global population. This pathogen is uniquely adapted to survive the highly acidic environment of the stomach by producing large amounts of the urease enzyme, which neutralizes gastric acid and allows the bacteria to penetrate the protective mucous layer. The H. pylori Antigen Screening (Stool) test at Lahore PCR Lab is a non-invasive, highly sensitive, and clinically specific diagnostic tool designed to detect the physical presence of H. pylori outer membrane proteins (antigens) in a patient’s stool sample.

Unlike serological blood tests, which detect antibodies that can persist in the bloodstream for months or even years after an infection has been successfully cleared, the stool antigen test only yields a positive result when there is an active, ongoing colonization. This makes it an invaluable asset for both initial diagnosis and post-treatment monitoring. The test utilizes advanced enzyme-linked immunosorbent assay (ELISA) or immunochromatographic technologies to identify specific bacterial antigens with exceptional accuracy. By evaluating the stool specimen, clinical pathologists at Lahore PCR Lab can confirm active infection, helping gastroenterologists and internal medicine specialists formulate targeted triple- or quadruple-therapy eradication regimens. This non-invasive approach is highly preferred over invasive upper gastrointestinal endoscopies and tissue biopsies, particularly for pediatric, geriatric, and symptomatic patients seeking a rapid and comfortable diagnostic experience in Lahore, Pakistan.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest level of diagnostic accuracy and to prevent false-negative or false-positive results, patients must strictly adhere to the following preparation guidelines before collecting their stool specimen for analysis at Lahore PCR Lab:

• Antibiotic Cessation: Patients must avoid taking any antibiotics for at least four weeks prior to the test, as these medications can suppress the bacterial load below detectable levels without completely eradicating the infection.
• Proton Pump Inhibitors (PPIs): Acid-suppressing medications such as omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole must be discontinued for at least two weeks before specimen collection, with the prescribing physician’s approval.
• Bismuth Compounds: Over-the-counter medications containing bismuth subsalicylate (such as Pepto-Bismol) must be avoided for at least two weeks prior to the test.
• H2 Receptor Antagonists: While PPIs must be stopped, some physicians may allow the use of mild H2 blockers (like famotidine) up to 24 hours before the test, though complete avoidance of all acid reducers is ideal if clinically tolerated.
• No Laxatives or Enemas: Patients should not use laxatives, mineral oil, or enemas before collecting the sample, as these substances can dilute the stool or interfere with the chemical assay.
• Sample Container: Use only the sterile, dry, wide-mouthed specimen container provided by Lahore PCR Lab or purchased from a reputable pharmacy. Do not collect stool from the toilet bowl water.

During the Procedure

The stool sample collection is a simple, non-invasive procedure performed by the patient in the comfort of their home. The process involves the following steps to maintain sample integrity:

• Hygiene First: Wash hands thoroughly with soap and water before beginning the collection process to prevent external bacterial contamination.
• Collection Method: Pass stool into a clean, dry receptacle or onto a clean plastic wrap stretched across the toilet seat. Ensure the stool does not come into contact with urine, toilet water, soap, or paper towels.
• Transferring the Sample: Using the spatula or spoon attached to the lid of the sterile specimen container, transfer a small portion of the stool (approximately the size of a walnut for solid stool, or 1 to 2 teaspoons for liquid stool) into the container.
• Securing the Container: Close the lid tightly to prevent leakage and contamination. Label the container clearly with the patient’s full name, age, gender, and the exact date and time of collection.
• Prompt Delivery: Deliver the specimen to Lahore PCR Lab as soon as possible, ideally within two hours of collection. If a delay is unavoidable, store the sample in a refrigerator (between 2°C and 8°C) for no more than 24 hours before transport. Do not freeze the sample.

When is an H. pylori Ag Screening (Stool) Performed?

Investigation of Chronic Dyspepsia and Indigestion

Physicians frequently request the H. pylori Stool Antigen test for patients presenting with persistent dyspepsia, characterized by upper abdominal pain, early satiety, bloating, and postprandial fullness. Because H. pylori damages the protective mucosal barrier of the stomach, it exposes the underlying tissue to corrosive gastric juices, leading to chronic inflammation. Identifying the presence of the bacterium allows clinicians to treat the root cause of dyspepsia rather than merely suppressing symptoms with antacids.

Diagnosis of Peptic Ulcer Disease (PUD)

Peptic ulcer disease, which includes both gastric and duodenal ulcers, is strongly associated with chronic H. pylori infection. Patients suffering from burning epigastric pain that worsens on an empty stomach or is temporarily relieved by food are prime candidates for this screening. The stool antigen test helps determine if an active H. pylori infection is the underlying driver of the ulceration, which is critical because treating the infection is essential for permanent ulcer healing and preventing recurrence.

Assessment of Unexplained Chronic Gastritis

Chronic superficial gastritis can progress to atrophic gastritis and intestinal metaplasia if left untreated. When patients present with chronic, vague abdominal discomfort, nausea, vomiting, or unexplained weight loss, the H. pylori stool antigen test is utilized to rule out or confirm bacterial-induced mucosal inflammation. Early detection and subsequent eradication therapy can reverse early inflammatory changes and prevent long-term mucosal damage.

Monitoring the Success of Eradication Therapy

One of the primary clinical indications for the H. pylori Stool Antigen test at Lahore PCR Lab is to confirm that the prescribed antibiotic and PPI regimen has successfully eradicated the bacteria. This follow-up test is typically performed at least four weeks after the completion of the entire treatment course and at least two weeks after stopping PPI therapy. A negative stool antigen result provides objective clinical confirmation of successful eradication.

Screening for Gastric Cancer Risk Factors

H. pylori is classified as a Group 1 carcinogen by the World Health Organization (WHO) due to its strong association with gastric adenocarcinoma and Mucosa-Associated Lymphoid Tissue (MALT) lymphoma. In patients with a strong family history of gastric malignancies or those presenting with persistent alarm symptoms (such as unexplained anemia or weight loss), this screening serves as a vital preventive tool to identify and eliminate a major modifiable risk factor for stomach cancer.

What Does an H. pylori Ag Screening (Stool) Detect?

The H. pylori Antigen Screening (Stool) test is highly specific and is designed to detect, rule out, or monitor several key clinical aspects of gastrointestinal health, including:

• Active colonization of the gastric mucosa by Helicobacter pylori bacteria.
• Presence of specific H. pylori outer membrane proteins (antigens) in the fecal specimen.
• Success or failure of triple- or quadruple-eradication therapy.
• Persistent infection in patients with refractory dyspeptic symptoms.
• Recurrence or reinfection of H. pylori after previously documented eradication.
• The underlying infectious cause of chronic active gastritis.
• The primary etiological agent responsible for duodenal ulceration.
• The primary etiological agent responsible for gastric ulceration.
• The infectious trigger for Mucosa-Associated Lymphoid Tissue (MALT) lymphoma.
• The presence of bacterial shedding, indicating viable replicating organisms in the gastrointestinal tract.
• The necessity for proceeding with invasive diagnostic procedures like upper endoscopy (EGD) and biopsy.
• The infectious origin of unexplained iron deficiency anemia.
• The cause of chronic halitosis (bad breath) associated with upper GI tract dysbiosis.
• The etiology of cyclic vomiting syndrome or recurrent nausea in pediatric patients.
• The presence of active bacterial proteins even in asymptomatic individuals with a family history of gastric cancer.
• The clearance of bacterial load post-treatment to guide the discontinuation of maintenance acid-suppressive therapy.

Turnaround Time and Report Access at Lahore PCR Lab

At Lahore PCR Lab, we understand that timely diagnostic results are crucial for reducing patient anxiety and initiating prompt medical treatment. The H. pylori Antigen Screening (Stool) is processed using state-of-the-art automated laboratory equipment under strict quality control protocols. The standard turnaround time for this test is typically within 12 to 24 hours from the time the specimen is received at the laboratory. Once the analysis is complete, the report undergoes a rigorous multi-level verification process by our qualified clinical pathologists to ensure absolute accuracy. Patients and their referring physicians can easily access the diagnostic reports online through the secure Lahore PCR Lab web portal or via WhatsApp. Physical copies of the reports can also be collected directly from our main collection centers in Lahore.

H. pylori Ag Screening (Stool) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
H. pylori Antigen Status	Negative (Absence of H. pylori antigens in stool)	Positive (Presence of H. pylori antigens, indicating active infection)
Stool Consistency	Formed to semi-formed	Loose, watery, or diarrheal (may indicate concurrent gastroenteritis or malabsorption)
Stool Color	Brown	Tarry black (melena, suggesting upper GI bleeding potentially from an H. pylori-induced ulcer)
Occult Blood (if co-evaluated)	Negative	Positive (indicates mucosal bleeding, erosive gastritis, or active peptic ulcer disease)
Fecal Leukocytes (if co-evaluated)	Absent	Present (indicates active mucosal inflammation or invasive bacterial co-infection)
Specimen Adequacy	Adequate sample volume without contamination	Inadequate sample, diluted sample, or sample contaminated with urine/toilet water (requires recollect)
Eradication Status (Post-Treatment)	Negative (Successful eradication of the bacterium)	Positive (Treatment failure, persistent infection, or bacterial resistance to antibiotics)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Lahore PCR Lab for H. pylori Ag Screening (Stool)?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified clinical pathologists, microbiologists, and laboratory technologists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, privacy, and convenience throughout the sample submission and reporting process.
• Quality Diagnostic Services: Lahore PCR Lab adheres to strict international quality control standards, ensuring highly reproducible and reliable test results.
• Professional Reporting: Our reports are comprehensive, easy to understand, and verified by senior medical specialists to facilitate seamless clinical decision-making.
• Modern Diagnostic Approach: We utilize advanced enzyme immunoassay (EIA) technologies that offer superior sensitivity and specificity compared to rapid card tests.
• Comfortable Environment: Our collection centers in Lahore are designed to provide a clean, hygienic, and welcoming environment for all patients.
• Convenient Location: Strategically located in Lahore, our main lab and collection points are easily accessible from all major areas of the city.
• Commitment to Accurate Diagnosis: We are dedicated to providing precise diagnostic insights that help clinicians choose the most effective treatment pathways for gastric health.